Vancouver, B.C. and Boston, MA, December 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for its...
Read More
Vancouver, B.C. and Boston, MA, December 18, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results...
Read More
Vancouver, B.C. and Boston, MA, December 3, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that management will present...
Read More
Vancouver, B.C. and Boston, MA, November 12, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported further progress toward verification...
Read More
Vancouver, B.C. and Boston, MA, – October 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the...
Read More
Vancouver, B.C. and Boston, MA, September 26, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met with...
Read More
Vancouver, B.C. and Boston, MA, August 27, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the...
Read More
Effect of blue-light cystoscopy on contemporary performance of urine cytology.
Freifeld Y, Lotan Y.
BJU Int. 2019 Aug;124(2):251-257. doi: 10.1111/bju.14574. Epub 2018 Oct 21.
PMID: 30281893 Clinical Trial.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f30281893%2f&c=E,1,4gBnj_ScTnVhwBTw8ZTLp7S7mC68k2Ma4z6o9uVSt3oJ29TSjrsvvscJ806oNWYD5Q-x6LPig5RzvNMUeugWqcO0WgmmGaUleVGPL3P5mF2xSG9luodBIjf3aL0,&typo=1
Vancouver, B.C. and Boston, MA, July 15, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedcontinued progress toward verification of its...
Read More
Vancouver, B.C. and Boston, MA, June 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under its stock option plan, it...
Read More
